CALM3, calmodulin 3, 808

N. diseases: 215; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 Biomarker disease BEFREE In the present study, we have analysed the growth, phenotypic, morphological and ultrastructural characteristics of four human PC-3 prostate carcinoma cell lines transduced with C-CAM1 retrovirus. 10359532 1999
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 Biomarker disease BEFREE Thus C-CAM1 recombinant adenovirus therapy may be a promising treatment for prostate cancer. 10226564 1999
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 AlteredExpression disease BEFREE Also, increased C-CAM1 expression can effectively inhibit the growth of prostate cancer. 10440873 1999
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 GeneticVariation disease BEFREE Therefore, C-CAM1 therapy is a new form of prostate cancer treatment. 10597733 1999
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 Biomarker disease BEFREE Recently, we demonstrated that an immunoglobulin-like cell adhesion molecule, C-CAM, acts as a tumor suppressor in prostate cancer. 8758907 1996
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 Biomarker disease BEFREE In this study, we further explored the possibility of applying C-CAM as a potential agent for developing prostate cancer gene therapy using an adenoviral delivery system. 7796410 1995